Patents Assigned to AELIX Therapeutics, S.L. - Justia Patents Search

Patents Assigned to AELIX Therapeutics, S.L.

Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes

Patent number: 11666651

Abstract: The present invention relates to immunogenic therapies for the treatment or prevention of a human immunodeficiency virus (HIV) infection or a disease associated with an HIV infection.

Type: Grant

Filed: November 12, 2020

Date of Patent: June 6, 2023

Assignee: AELIX Therapeutics, S.L.

Inventors: Christian Brander, Beatriz Mothe-Pujadas